Innovative Industrial Properties Inc vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Innovative Industrial Properties Inc trades at $51.85 (market cap $1.43B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.67 (market cap $2.27B). The key difference: SELLAS Life Sciences Group Inc. Common Stock is the larger of the two by market cap, and Innovative Industrial Properties Inc pays a 14.64% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| IIPR | SLS | |
|---|---|---|
Market Cap | $1.43B | $2.27B |
Volume | 394,222 | 4,179,659 |
Sector | Real Estate | Health |
52-Week High | $64.67 | $15.46 |
52-Week Low | $44.58 | $1.39 |
Typical Hold Time | 86 Days | — |
Enterprise Value | $1.96B | $2.14B |
Dividend Yield | 14.64% | — |
Signals from Pluang's Aura AI — not financial advice
IIPR trades at $52.36, up 2.21% today, with a bearish technical signal but oversold RSI readings. The company reported a Q2 2026 EPS beat of $1.36 versus $1.02 expected, though revenue declined to $266M in 2025. Valuation metrics appear attractive with a P/E of 11.75 and P/B of 0.83, while a recent $245 million mezzanine loan commitment signals active capital deployment.
The outlook balances a high dividend yield near 13% against tenant default risks and declining operating cash flow. Analyst consensus is mixed with a $84.67 price target, but the stock faces headwinds from sector volatility and earnings inconsistency, requiring careful risk assessment for income-focused investors.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Innovative Industrial Properties Inc is a real estate investment trust engaged in the acquisition, ownership, and management of specialized industrial properties leased to state-licensed operators for their regulated medical-use cannabis facilities. It conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by Operating Partnership, directly or through subsidiaries. Its property portfolio is spread across the United States.
Read more on IIPR →SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →